Publishers' Bookfair Opens
Registration/Course Enrollment Opens
IS1. New Augmentation Strategies in Depression for Better
Supported by GlaxoSmithKline
IS2. Strategies for Maintaining Wellness in Patients With Bipolar
Disorder: Moving Beyond Efficacy to EffectivenessSupported by
Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.
IS3. Navigating the Maze: Understanding Methods, Results, and Risks in
Psychiatric ResearchSupported by Forest Laboratories, Inc.
IS4. Bridging Sleep Science and Public PolicySupported by
Takeda Pharmaceuticals North America, Inc.
IS5. Mania in Special PopulationsSupported by Shire US,
IS6. Verging on Reality: Emergent Therapeutic Approaches for
SchizophreniaSupported by Bristol-Myers Squibb Company and Otsuka
America Pharmaceutical, Inc.
IS7. Bipolar Disorder: Creating a Consensus From Science to Public
PolicySupported by Solvay Wyeth Pharmaceuticals
IS8. Treatment-Resistant Depression: New Data, New ApproachesSupported by Cyberonics, Inc.